CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,850,000 | -56.7% | 2,074,000 | -54.7% | 0.01% | -66.7% |
| Q1 2019 | $4,273,000 | -43.9% | 4,574,000 | -49.6% | 0.04% | -58.5% |
| Q4 2018 | $7,622,000 | +45.7% | 9,074,000 | +62.8% | 0.09% | +56.7% |
| Q3 2018 | $5,232,000 | -13.1% | 5,574,000 | 0.0% | 0.06% | -34.8% |
| Q2 2018 | $6,020,000 | -7.1% | 5,574,000 | 0.0% | 0.09% | -25.8% |
| Q1 2018 | $6,483,000 | -65.9% | 5,574,000 | -60.4% | 0.12% | -76.9% |
| Q4 2017 | $19,008,000 | +35.5% | 14,074,000 | +55.1% | 0.54% | +8.9% |
| Q3 2017 | $14,030,000 | -8.9% | 9,074,000 | 0.0% | 0.49% | +17.7% |
| Q2 2017 | $15,403,000 | +68.5% | 9,074,000 | +28.3% | 0.42% | +83.0% |
| Q1 2017 | $9,143,000 | +244.1% | 7,074,000 | +174.8% | 0.23% | +179.3% |
| Q4 2016 | $2,657,000 | -54.0% | 2,574,000 | -57.6% | 0.08% | -34.9% |
| Q3 2016 | $5,770,000 | -9.7% | 6,074,000 | -33.1% | 0.13% | +3.3% |
| Q2 2016 | $6,390,000 | +55.6% | 9,074,000 | +51.2% | 0.12% | -2.4% |
| Q1 2016 | $4,106,000 | -20.4% | 6,000,000 | 0.0% | 0.12% | -9.4% |
| Q4 2015 | $5,160,000 | -55.9% | 6,000,000 | -14.3% | 0.14% | -49.3% |
| Q3 2015 | $11,705,000 | – | 7,000,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |